New technologies permit safe abortion at less than six weeks' gestation and provide timely detection of ectopic gestation - 10/09/11
Abstract |
OBJECTIVE: The previously held dictum that elective abortion before 6 weeks' gestation carried greater risks than a later procedure was challenged by this protocol.
STUDY DESIGN: This study evaluated a protocol for abortion before the customary 6 weeks' gestation. Patients willing to return to the clinic within 72 hours were given the option of elective abortion even when no gestational sac could be visualized with transvaginal ultrasonography. When no chorionic membrane with villi was seen in the curettings, postoperative serum levels of β-human chorionic gonadotropin confirmed complete evacuation or diagnosed ectopic pregnancy.
RESULTS: In 1530 abortion procedures at <6 weeks' gestation by ultrasonographic criteria no serious complications occurred. In addition, 9 (0.67%) unsuspected ectopic pregnancies were diagnosed.
CONCLUSIONS: Abortion before 6 weeks' gestation is safe, given close surveillance. Early termination combined with vaginal ultrasonography and follow-up with β-human chorionic gonadotropin measurements allows diagnosis of early, unsuspected ectopic pregnancy. Ectopic pregnancy was found to be uncommon in women requesting early abortion. (Am J Obstet Gynecol 1997;176:1101-6.)
Le texte complet de cet article est disponible en PDF.Keywords : Elective abortion, serum β-human chorionic gonadotropin, vaginal ultrasonography, ectopic pregnancy
Plan
 | From Planned Parenthood of Houston and Southeast Texasaand the Department of Obstetrics and Gynecology, Baylor College of Medicine.b |
| Reprint requests: Jerry Edwards, MD, Planned Parenthood of Houston and Southeast Texas, 3601 Fannin, Houston, TX 77004. |
 | 0002-9378/97 $5.00 + 06/1/80932 |
Vol 176 - N° 5
P. 1101-1106 - mai 1997 Retour au numéro
Article précédent
- Do low-risk pregnant women with antiphospholipid antibodies need to be treated?
- Susan Cowchock, E.Albert Reece, For the Organizing Group of the Antiphospholipid Antibody Treatment Trial
- Polymerase chain reaction determination of RhC, Rhc, and RhE blood types: An evaluation of accuracy and clinical utility
- Jerome Yankowitz, Sheng Li, Carl P. Weiner, From the Departments of Obstetrics and Gynecology and Pediatrics, University of Iowa College of Medicine.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?